NRx Pharmaceuticals, Inc. (NRXP) PT Raised to $5 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts NRXP Hot Sheet
Price: $3.34 --0%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo raised the price target on NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to $5.00 (from $4.75) while maintaining a Buy rating.
You May Also Be Interested In
- SanDisk (SNDK) PT Raised to $1,600 at RBC Capital
- LENSAR Inc. (LNSR) PT Raised to $13 at Lake Street
- Volkswagen AG (VOW:GR) (VWAGY) PT Lowered to EUR120 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
